Unipres Corporation Just Reported A Surprise Loss: Here’s What Analysts Think Will Happen Next

Nov 17, 2026
unipres-corporation-just-reported-a-surprise-loss:-here’s-what-analysts-think-will-happen-next

Last week saw the newest half-yearly earnings release from Unipres Corporation (TSE:5949), an important milestone in the company’s journey to build a stronger business. Revenues of JP¥74b beat expectations by 2.6%. Unfortunately statutory earnings per share (EPS) fell well short of the mark, turning in a loss of JP¥17.06 compared to previous analyst expectations of a profit. This is an important time for investors, as they can track a company’s performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. We’ve gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10bn in marketcap – there is still time to get in early.

earnings-and-revenue-growth
TSE:5949 Earnings and Revenue Growth November 16th 2026

Taking into account the latest results, the current consensus, from the two analysts covering Unipres, is for revenues of JP¥306.3b in 2027. This implies a measurable 6.2% reduction in Unipres’ revenue over the past 12 months. Unipres is also expected to turn profitable, with statutory earnings of JP¥103 per share. In the lead-up to this report, the analysts had been modelling revenues of JP¥311.7b and earnings per share (EPS) of JP¥109 in 2027. The analysts seem to have become a little more negative on the business after the latest results, given the small dip in their earnings per share numbers for next year.

View our latest analysis for Unipres

It might be a surprise to learn that the consensus price target was broadly unchanged at JP¥990, with the analysts clearly implying that the forecast decline in earnings is not expected to have much of an impact on valuation.

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. We would highlight that revenue is expected to reverse, with a forecast 12% annualised decline to the end of 2027. That is a notable change from historical growth of 4.6% over the last five years. By contrast, our data suggests that other companies (with analyst coverage) in the same industry are forecast to see their revenue grow 3.9% annually for the foreseeable future. It’s pretty clear that Unipres’ revenues are expected to perform substantially worse than the wider industry.

The Bottom Line

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. The consensus price target held steady at JP¥990, with the latest estimates not enough to have an impact on their price targets.

With that said, the long-term trajectory of the company’s earnings is a lot more important than next year. We have analyst estimates for Unipres going out as far as 2029, and you can see them free on our platform here.

However, before you get too enthused, we’ve discovered 1 warning sign for Unipres that you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

Leave a comment